Abstract
The goal of risk stratification of CVD in patients with CKD is to lead to effective and early intervention and to prevent the adverse outcomes associated with this complex multisystem disease that is characteristic of growing number of patients with CKD in the general population and of patients receiving dialysis therapy or kidney transplantation. By 2030, there will be 2.24 million patients with ESRD in the United States, and approximately 1.3 million of these cases of ESRD will be caused by diabetes mellitus. Thus, CVD in this high-risk population presents a challenge for the nephrology and the cardiology community.
Original language | English (US) |
---|---|
Pages (from-to) | 343-362 |
Number of pages | 20 |
Journal | Cardiology Clinics |
Volume | 23 |
Issue number | 3 |
DOIs | |
State | Published - Aug 1 2005 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine